Clinical Trials Logo

Clinical Trial Summary

Dento- alveolar or dental structural diseases that affect the floor of the maxillary sinus can cause maxillary sinusitis which is known as odontogenic maxillary sinusitis (OMS). Many treatment protocols have been documented to treat OMS. However, There is no unanimity among clinicians on how and who should treat OMS, whether is it otolaryngologist, oral/maxillofacial surgeons, or dentist. Therefore, this study will be will be enrolled to evaluate the efficacy of the Single-step Functional Sinus endoscopy and trans-oral surgery in the management of maxillary sinusitis raised from Odontogenic origin via Department- integrated therapy.


Clinical Trial Description

The OMS is a well-known but understudied kind of sinusitis that necessitates a treatment regimen different from non-odontogenic sinusitis. It requires specialized attention because it differs in its pathophysiology, microbiology, diagnosis, and therapy than other forms of non-odontogenic sinusitis. There are several surgical techniques have been published to treat odontogenic maxillary sinusitis, such as transoral, transnasal endoscopic, or combined techniques. Multiple specialists are daily facing patients with maxillary sinusitis either odontogenic or non-odontogenic, including otolaryngologist, maxillofacial/oral, and dental surgeons. The direct transoral method, which involves making a bone window in the anterolateral maxillary wall, is more familiar to maxillofacial/oral surgeons, whereas the transnasal endoscopic approach is gaining favor, particularly among otolaryngologists. There is no unanimity among clinicians on how and who should treat OMS, whether it is otolaryngologist, maxillofacial, or oral surgeon. This is one of the reasons why the results are frequently challenged as reported by others. Therefore, this study will be will be enrolled to evaluate the efficacy of the Single-step Functional Sinus endoscopy and trans-oral surgery in the management of maxillary sinusitis raised from Odontogenic origin via Department- integrated therapy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06130176
Study type Interventional
Source Qassim University
Contact Ghada A Khalifa, Professor
Phone 00966504840248
Email g.khalifa@qu.edu.sa
Status Recruiting
Phase N/A
Start date November 11, 2018
Completion date January 1, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04903418 - Assessment of Relationship Between Maxillary Sinus Floor and Maxillary Posterior Teeth Root Tips Position
Completed NCT00683371 - Microarray Analysis of Sinus Samples From Patients With and Without Chronic Rhinosinusitis N/A
Completed NCT00236652 - A Study Evaluating the Safety and Efficacy of Treating Sinus Infection With Levofloxacin 750 mg for 5 Days. Phase 3
Recruiting NCT04241016 - Endoscopic Sinus Surgery in Recurrent Acute Rhinosinusitis N/A
Not yet recruiting NCT03083392 - Endosseous Oroantral Port for Minimal Intervention in Treating Chronic Sinusitis N/A
Completed NCT00668304 - Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With Avelox Phase 4
Recruiting NCT04645511 - Balloon Sinuplasty Efficiency in Maxillary Rhinosinusitis. N/A
Not yet recruiting NCT02931604 - Study Designed to Clinically Evaluate Sinus Wash Device Prototypes N/A
Completed NCT00643409 - A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Sinus Infections in Adults Phase 3
Terminated NCT00245440 - Study to Measure the Impact of Antibiotics on Bacterial Flora in Adults With Acute Sinusitis Phase 4
Completed NCT00537563 - AMS VS MOXI Ketek vs Avelox in AMS Phase 3
Completed NCT00249210 - A Study of the Safety and Effectiveness of Levofloxacin Compared With Amoxicillin/Clavulanate Potassium in the Treatment of Adults With Rapid Onset of Severe Inflammation/Infection of the Sinuses Phase 3
Completed NCT01032174 - Non-Interventional Open Label Prospective Comparative Observational Study Of Evaluation Of Compliance In The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Of Acute Bacterial Maxillary Sinusitis N/A